Doctor profile · Federal record
Dr. Lorinda Liles, NP-C
Family Nurse Practitioner (CMS: Nurse Practitioner) · Dallas, TX
- NPI 1104207414
- Accepts Medicare
- MIPS 93.6 / 100 · 2023
- 13 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
9900 N Central Expy Ste 215
Dallas, TX 752310929
(214) 396-4950
fax (877) 423-5360 - Additional location
-
3100 Independence Pkwy Ste 103A
Plano, TX 750751964
(972) 596-4200
Credentials & registration
- NPI registered
- June 2015 — 11 yrs on file
- Profile last updated
- February 15, 2023
- Year of graduation
- 2013 — 13 yrs since
- Specialty taxonomy
- 363LF0000X — NUCC code
- State license (1)
- Texas #AP127308
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1104207414. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
125
Distinct HCPCS
2
Medicare allowed
$9,061
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 82 | 28 | $65 | |
99309 |
Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | 43 | 16 | $87 |
In context: peer comparison
Among 168 peers in Dallas Family Nurse Practitioner, average services per provider: 416. This provider delivers 0.3× the peer median.Open Payments
Industry payments received
All-time total
$1,256
Transactions
53
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 6 | $299.65 | |
| Opko Pharmaceuticals, LLC | 15 | $203.91 | |
| Bayer Healthcare Pharmaceuticals INC. | 6 | $108.26 | |
| Novartis Pharmaceuticals Corporation | 4 | $76.56 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 4 | $70.18 | |
| Genzyme Corporation | 2 | $61.15 | |
| Renalytix Ai, INC. | 2 | $45.19 | |
| Ardelyx, INC. | 2 | $44.52 | |
| Akebia Therapeutics INC | 2 | $44.29 | |
| CorMedix INC. | 2 | $44.11 | |
| Fresenius USA Marketing, INC. | 2 | $42.88 | |
| Otsuka America Pharmaceutical, INC. | 2 | $40.98 | |
| Travere Therapeutics, INC. | 1 | $36.55 | |
| Ani Pharmaceuticals, INC. | 2 | $32.90 | |
| Lilly USA, LLC | 1 | $23.94 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
41
Patients
0
Total drug cost
$10,496
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Amlodipine Besylate | Generic | 16 | 0 | $142 |
| Levothyroxine Sodium | Generic | 14 | 0 | $176 |
| Farxiga (Dapagliflozin Propanediol) | Brand | 11 | 0 | $10,178 |
Frequently asked questions
What is Dr. Lorinda Liles's medical specialty?
Dr. Lorinda Liles practices Family Nurse Practitioner in Dallas, TX.
Where does Dr. Lorinda Liles practice?
Dr. Lorinda Liles practices at 9900 N Central Expy Ste 215, Dallas, TX 752310929. Office phone: 2143964950.
What is Dr. Lorinda Liles's NPI?
Dr. Lorinda Liles's National Provider Identifier (NPI) is 1104207414, issued by NPPES.
Does Dr. Lorinda Liles accept Medicare assignment?
Yes. Dr. Lorinda Liles accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Lorinda Liles commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Subsequent nursing facility care with moderate level of medical decision making (HCPCS 99309). Source: CMS Medicare Physician & Other Practitioners file.